Shorted @$3.70 - borrowed shares too late and missed out on the $3.83 ask...
A Sykes-like short. Stock would not have been able to sustain the unusually high volume it had in it's run up from $2 to $4.5. The news of its medical device being used at University of Utah doesn't justify doubling the company's value. We'll have to see more use and an actual marketable revenue generating product before I''ll be buying -- could be a long time.
No comments:
Post a Comment